American journal of clinical oncology
Journal
Overview
publication venue for
-
Ureteral stenosis after postprostatectomy intensity-modulated radiotherapy.
2010
-
Hyperglycemic complications associated with adjuvant chemotherapy of breast cancer. A cancer and leukemia group B (CALGB) study.
1986
-
Executive Summary of the American Radium Society Appropriate Use Criteria for Management of Squamous Cell Carcinoma of the Cervical Esophagus: Systematic Review and Guidelines..
48.
2025
-
Impact of Surveillance Imaging in Patients With HPV-Associated Oropharyngeal Carcinoma Treated With Definitive Radiation and Chemotherapy.
2024
-
Racial Disparities in Endometrial Cancer Clinical Trial Representation: Exploring the Role of Eligibility Criteria.
2024
-
Long COVID in Cancer: A Matched Cohort Study of 1-year Mortality and Long COVID Prevalence Among Patients With Cancer Who Survived an Initial Severe SARS-CoV-2 Infection..
46.
2023
-
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment..
44.
2021
-
Surveillance Only for High-risk FIGO Stage IA/IB Malignant Ovarian Germ Cell Tumors: Results From a National Cancer Database..
44.
2021
-
Effect of Age on Cancer-specific Mortality in Patients With Urothelial Carcinoma of the Urinary Bladder: A Population-based Competing-risks Analysis Across Disease Stages..
43.
2020
-
Food Intake During Cancer Therapy: A Systematic Review..
43.
2020
-
Incidental Coronary Artery Calcium on Breast Radiation Therapy Planning Scans Identifies Patients for Cardiac Preventive Therapy..
43.
2020
-
The Effect of Systemic Chemotherapy on Survival in Patients With Localized, Regional, or Metastatic Adenocarcinoma of the Urinary Bladder..
43.
2020
-
Cardiac Monitoring for Thoracic Radiation Therapy: Survey of Practice Patterns in the United States..
43.
2020
-
Early Impact of the Affordable Care Act and Medicaid Expansion on Racial and Socioeconomic Disparities in Cancer Care..
43.
2020
-
Disparities in the Use of Adjuvant External Beam Radiation Therapy in Node-positive Cervical Cancer Patients Following Hysterectomy..
43.
2020
-
Analysis of Outcomes in Patients With BRCA1/2 Breast Cancer Mutations Treated With Accelerated Partial Breast Irradiation (APBI)..
42.
2019
-
The Utility of Diagnostic Laparoscopy in Patients Being Evaluated for Cytoreductive Surgery and Hyperthermic Peritoneal Chemotherapy..
41.
2018
-
Surgical Intervention in Gastric Carcinoid is Associated With Improved Survival in Local and Regional Disease..
41.
2018
-
Prognostic Factors, Treatment, and Outcomes in Early Stage, Invasive Papillary Breast Cancer: A SEER Investigation of Less Aggressive Treatment in a Favorable Histology..
41.
2018
-
Targeted Prostate Biopsy Gleason Score Heterogeneity and Implications for Risk Stratification..
41.
2018
-
Patterns of Long-term Cancer Survivorship Care in a National Cancer Institute-Designated Comprehensive Cancer Center..
40.
2017
-
Older Patients With Early-stage Breast Cancer: Adjuvant Radiation Therapy and Predictive Factors for Cancer-related Death..
40.
2017
-
Adjuvant Gemcitabine and Gemcitabine-based Chemoradiotherapy Versus Gemcitabine Alone After Pancreatic Cancer Resection: The Indiana University Experience..
40.
2017
-
Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma..
39.
2016
-
Survival Outcomes of Primary Intraocular Lymphoma: A Single-institution Experience..
39.
2016
-
Concurrent Chemoradiotherapy With Cisplatin Versus Cetuximab for Squamous Cell Carcinoma of the Head and Neck..
39.
2016
-
Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy..
38.
2015
-
Primary angiosarcoma of bone: a retrospective analysis of 60 patients from 2 institutions..
37.
2014
-
Radiation therapy in the treatment of minor salivary gland tumors..
37.
2014
-
Phase II trial of cetuximab plus cisplatin and irinotecan in patients with cisplatin and irinotecan-refractory metastatic esophagogastric cancer..
37.
2014
-
Lymph node ratio is an independent prognostic factor after resection of periampullary malignancies: data from a tertiary referral center in the middle East..
37.
2014
-
Is there a cause-specific survival benefit of postmastectomy radiation therapy in women younger than age 50 with T3N0 invasive breast cancer? A SEER database analysis: outcomes by receptor status/race/age: analysis using the NCI Surveillance, Epidemiology, and End Results (SEER) database..
36.
2013
-
Radiotherapy in metastatic ewing sarcoma..
36.
2013
-
Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance..
36.
2013
-
Dose escalation and pharmacokinetics study of enzastaurin and sunitinib versus placebo and sunitinib in patients with metastatic renal cell carcinoma..
35.
2012
-
Why is partial-breast irradiation still investigational..
35.
2012
-
A phase I trial of sorafenib plus gemcitabine and capecitabine for patients with advanced renal cell carcinoma: New York Cancer Consortium Trial NCI 6981..
34.
2011
-
A phase II study of gemcitabine in combination with radiation therapy in patients with localized, unresectable, pancreatic cancer: a Hoosier Oncology Group study..
34.
2011
-
Comparative analysis of outcome in patients with hepatocellular carcinoma exceeding the milan criteria treated with liver transplantation versus partial hepatectomy..
34.
2011
-
Sarcomatoid-variant renal cell carcinoma: treatment outcome and survival in advanced disease..
34.
2011
-
Targeting mutated K-ras in pancreatic adenocarcinoma using an adjuvant vaccine..
34.
2011
-
Chemotherapy significantly increases the risk of radiation pneumonitis in radiation therapy of advanced lung cancer..
34.
2011
-
Phase I/II trial of sunitinib plus gefitinib in patients with metastatic renal cell carcinoma..
33.
2010
-
Radiotherapy after surgical resection for head and neck mucosal melanoma..
33.
2010
-
Phase II study of paclitaxel plus the protein kinase C inhibitor bryostatin-1 in advanced pancreatic carcinoma..
33.
2010
-
A phase I trial of oblimersen sodium in combination with cisplatin and 5-fluorouracil in patients with advanced esophageal, gastroesophageal junction, and gastric carcinoma..
33.
2010
-
Perineural invasion after preoperative chemotherapy predicts poor survival in patients with locally advanced gastric cancer: gene expression analysis with pathologic validation..
32.
2009
-
Permanent interstitial reirradiation with 198Au as salvage therapy for low volume recurrent gynecologic malignancies: a single institution experience..
32.
2009
-
G3139 (Genasense) in patients with advanced merkel cell carcinoma..
32.
2009
-
Dermal lymphatic invasion and inflammatory breast cancer are independent predictors of outcome after postmastectomy radiation..
32.
2009
-
Evaluation of different methods of 18F-FDG-PET target volume delineation in the radiotherapy of head and neck cancer..
31.
2008
-
Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancer..
31.
2008
-
Preliminary report of the effect of high-dose adjuvant intensity modulated radiation therapy on the sural nerve graft for cavernosal nerve sacrifice after radical prostatectomy..
30.
2007
-
Clinical outcomes after reirradiation of paraspinal tumors..
29.
2006
-
Systemic treatment of malignant thymoma: a decade experience at a single institution..
29.
2006
-
Tolerance of endorectal balloon in 396 patients treated with intensity-modulated radiation therapy (IMRT) for prostate cancer..
29.
2006
-
A Phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers..
28.
2005
-
Inflammatory local recurrence after breast-conservation therapy for noninflammatory breast cancer..
28.
2005
-
Outcome analysis for stage IE and IIE thyroid lymphoma..
27.
2004
-
Phase II trial of vinorelbine plus doxorubicin in relapsed small-cell lung cancer: CALGB 9332..
27.
2004
-
Concomitant boost of stratified target area with gamma knife radiosurgery: a treatment planning study..
26.
2003
-
Phase I/II trial of accutane as a potentiator of carboplatin and paclitaxel in squamous cell carcinomas..
25.
2002
-
Influence of gamma knife radiosurgery on the quality of life in patients with brain metastases..
25.
2002
-
Standard off-cord lung oblique fields do not include the entire mediastinum: a computed tomography simulator study..
23.
2000
-
Comparison of outcomes of radical prostatectomy with and without adjuvant pelvic irradiation in patients with pathologic stage C (T3N0) adenocarcinoma of the prostate..
22.
1999
-
Phase II trial of topotecan in advanced breast cancer: a Cancer and Leukemia Group B study..
22.
1999
-
Phase II trial of topotecan administered as a 21-day continuous infusion in previously untreated patients with stage IIIB and IV non-small-cell lung cancer..
21.
1998
-
A phase II study of topotecan administered five times daily in patients with advanced gastric cancer..
20.
1997
-
Phase II study of ZD1694 in patients with advanced gastric cancer..
19.
1996
-
Ifosfamide plus high-dose cisplatin in patients with non-small cell lung cancer previously treated with chemotherapy..
18.
1995
-
Initial brachytherapy in the breast conservation approach to breast cancer..
18.
1995
-
Syndrome of acute dyspnea related to combined mitomycin plus vinca alkaloid chemotherapy..
18.
1995
-
A phase 1-2 trial of superselective carboplatin, low-dose infusional 5-fluorouracil and concurrent radiation for high-grade gliomas..
18.
1995
-
Randomized phase II trial comparing two versus three doses of ondansetron when used in combination with dexamethasone in patients receiving cisplatin > or = 100 mg/m2..
17.
1994
-
Phase II trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2..
16.
1993
-
A study of oral etoposide, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small-cell lung cancer. A Mid-Atlantic Oncology Program study..
15.
1992
-
Extrahepatic biliary system cancer: an update of a combined modality approach..
14.
1991
-
Limited small-cell lung cancer: do favorable short-term results predict ultimate outcome?.
14.
1991
-
Phase II trial of amonafide in patients with stage III and IV non-small-cell lung cancer..
14.
1991
-
Management of carcinoma of the esophagus: the role of radiotherapy..
14.
1991
-
Metastatic adenocarcinomas of unknown primary site. Prognostic variables and treatment results..
13.
1990
-
Phase II trial of 10-Edam in patients with advanced colorectal carcinoma..
13.
1990
-
Recombinant gamma-interferon has activity in chronic myeloid leukemia..
13.
1990
-
Free-standing cancer centers: rationale for improving cancer care delivery..
12.
1989
-
Dose-ranging antiemetic trial of high-dose oral metoclopramide..
12.
1989
-
Phase II trial of trimetrexate in patients with stage III and IV non-small-cell lung cancer..
12.
1989
-
The effect of surgical debulking on the response of patients with ovarian carcinoma to chemotherapy..
11.
1988
-
A phase II trial of streptozotocin and adriamycin in advanced APUD tumors..
11.
1988
-
Etoposide (VP-16) in the treatment of advanced adenocarcinoma of the pancreas..
11.
1988
-
Phase II trial of menogarol in the treatment of advanced adenocarcinoma of the pancreas..
11.
1988
-
Implementation of the group sequential methodology in a randomized trial in metastatic colorectal carcinoma..
11.
1988
-
Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice..
10.
1987
-
Phase 1 trial of levonantradol in chemotherapy-induced emesis..
8.
1985
-
Phase II trial of oral 4-demethoxydaunorubicin in patients with non-small cell lung cancer..
8.
1985
-
Chemotherapy of metastatic sweat gland carcinoma. A retrospective review..
8.
1985
-
Cisplatin nephrotoxicity. Correlation with plasma platinum concentrations..
8.
1985
-
MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas..
7.
1984
-
Phase II trial of 1,2-diaminocyclohexane-(4-carboxyphthalato) platinum(II) (DACCP) in colorectal carcinoma..
7.
1984
-
VP-16-213 and cisplatin in the treatment of patients with refractory germ cell tumors..
7.
1984
-
A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer. A Cancer and Leukemia Group B study..
7.
1984
-
Clinical and pathological evaluation of response to chemotherapy in patients with esophageal carcinoma..
6.
1983
-
Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methanesulfon-m-anisidide) in patients with adenocarcinoma of the pancreas..
6.
1983
-
Phase II evaluation of DON (6-diazo-5-oxo-L-norleucine) in patients with advanced colorectal carcinoma..
5.
1982
-
Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma..
5.
1982
-
Pharmacokinetics of cisplatin regional hepatic infusions..
5.
1982
-
Phase II trials of methylglyoxal-bis (guanylhydrazone)..
5.
1982
-
Phase II trial of VP-16-213 in non-small-cell lung cancer..
5.
1982
-
Laryngeal cancer in patients with acquired immunodeficiency syndrome..
21.
1998
-
Reirradiation in the era of IMRT: a dream or reality?.
28.
2005
-
Treating Locally Advanced Cervical Cancer With Concurrent Chemoradiation Without Brachytherapy in Low-resource Countries.
2016
-
Cancer Survivorship and Models of Survivorship Care: A Review.
2015
-
Immune-priming of the tumor microenvironment by radiotherapy: rationale for combination with immunotherapy to improve anticancer efficacy.
2015
-
ACR Appropriateness Criteria® management of locoregionally advanced squamous cell carcinoma of the vulva.
2013
-
Patient responses to ipilimumab, a novel immunopotentiator for metastatic melanoma: how different are these from conventional treatment responses?
2012
-
ACR Appropriateness Criteria® definitive therapy for early-stage cervical cancer.
2012
-
Multiple myeloma, painful neuropathy, acupuncture?
2009
-
Primary mediastinal large B-cell lymphoma: clinical study of a distinct clinical entity and treatment outcome in 20 patients: review of the literature.
2004
-
Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature.
2003
-
Brachytherapy.
1988
-
ACR appropriateness Criteria® advanced stage endometrial cancer.
2014
Identity
ISO Abbreviation
Linking ISSN
International Standard Serial Number (ISSN)
Electronic International Standard Serial Number (EISSN)